The Nifty extended its losing streak with a sixth consecutive decline, slipping below the 25,000 support level amid broad-based selling, especially in pharma and IT stocks. Analysts warn of further downside if 24,500 breaks, though a recovery remains possible. Stock recommendations include Ashok Leyland, Dr Agarwal’s Health Care, Dixon, and Anant Raj.
Positive Breakout: These 9 stocks cross above their 200 DMAs
In the Nifty 500 pack, 15 stocks saw their closing prices cross above their 200-day moving average (DMA) on July 1, 2026. Of these, we
July 2, 2026